GlassScriptIstent Inject Trabecular Micro-Bypass System Model G2-M-Is
Payments companies reported to CMS as associated with Istent Inject Trabecular Micro-Bypass System Model G2-M-Is. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Istent Inject Trabecular Micro-Bypass System Model G2-M-Is, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Istent Inject Trabecular Micro-Bypass System Model G2-M-Is
These are the largest totals companies reported as associated with Istent Inject Trabecular Micro-Bypass System Model G2-M-Is. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Iqbal Ahmed | Salt Lake City, UT | Ophthalmology | $47,437.50 |
| John Micheletti | Houston, TX | Ophthalmology | $31,313.35 |
| Lisa Nijm | Springfield, IL | Ophthalmology | $25,000.00 |
| Sahar Bedrood | Pasadena, CA | Retina Specialist | $24,183.20 |
| Mark Gallardo | Las Cruces, NM | Ophthalmology | $17,625.40 |
| Christy Benson | Des Moines, IA | Ophthalmology | $14,041.38 |
| Inder Singh | Racine, WI | Ophthalmology | $13,625.00 |
| Evan Schoenberg | Atlanta, GA | Ophthalmology | $11,125.00 |
| Manjool Shah | Ann Arbor, MI | Ophthalmology | $10,894.48 |
| Arkadiy Yadgarov | Atlanta, GA | Glaucoma Specialist | $10,309.44 |
Prescribed Istent Inject Trabecular Micro-Bypass System Model G2-M-Is?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.